The American Cancer Society estimates that this year in the United States, there will be 268,490 new cases of prostate cancer. It also estimates that 34,500 men will die from the cancer in 2022. Other than skin cancer, prostate cancer is the most common cancer in American men. These stark statistics are why the California … Continue reading The California Institute for Regenerative Medicine (CIRM) awards $5.8 million for prostate cancer research to USC
prostate cancer
Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
While there have been some encouraging advances in treating cancer in recent decades, there are still many cancers that either resist treatment or recur after treatment. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investing in a therapy targeting some of these hard-to-treat tumors. BioEclipse Therapeutics Inc. was awarded nearly … Continue reading Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
Creating a New Model for Diversity in Scientific and Medical Research
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Nature Cell Biology cover The global pandemic has highlighted many of the inequities in our health care system, with the virus hitting communities of color the hardest. That has led to calls for greater diversity, equity and inclusion at every level of scientific research and, ultimately, … Continue reading Creating a New Model for Diversity in Scientific and Medical Research
Blocking pancreatic cancer stem cells
John Cashman Cancer stem cells are one of the main reasons why cancers are able to survive surgery, chemotherapy and radiation. They are able to hide from those therapies and, at a future date, emerge and spread the cancer in the body once again. Jionglia Cheng, PhD. Jionglia Cheng, PhD., the lead author of a … Continue reading Blocking pancreatic cancer stem cells
Rave reviews for new Killer-T Cell study
Anytime you read a news headline that claims a new discovery "may treat all cancer" it's time to put your skeptic's hat on. After all, there have been so many over-hyped "discoveries" over the years that later flopped, that it would be natural to question the headline writer. And yet, this time, maybe, this one … Continue reading Rave reviews for new Killer-T Cell study
Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
A new independent report says developing stem cell treatments and cures for some of the most common and deadly diseases could produce multi-billion dollar benefits for California in reduced healthcare costs and improved quality and quantity of life. The report, by researchers at the University of Southern California’s Leonard D. Schaeffer Center for Health Policy … Continue reading Predicting the Impact of Stem Cell Cures on Healthcare Burden in California
Research Targeting Prostate Cancer Gets Almost $4 Million Support from CIRM
A program hoping to supercharge a patient’s own immune system cells to attack and kill a treatment resistant form of prostate cancer was today awarded $3.99 million by the governing Board of the California Institute for Regenerative Medicine (CIRM) In the U.S., prostate cancer is the second most common cause of cancer deaths in men. … Continue reading Research Targeting Prostate Cancer Gets Almost $4 Million Support from CIRM
Stem cell study holds out promise for kidney disease
Kidney failure is the Rodney Dangerfield of diseases, it really doesn’t get the respect it deserves. An estimated 660,000 Americans suffer from kidney failure and around 47,000 people die from it every year. That’s more than die from breast or prostate cancer. But now a new study has identified a promising stem cell candidate that … Continue reading Stem cell study holds out promise for kidney disease
New developments in prostate cancer from UCLA
Today we’re bringing you a research update from a CIRM-funded team at UCLA that’s dedicated to finding a cure for prostate cancer. The team is led by Dr. Owen Witte, the director of the UCLA Broad Stem Cell Research Center and a Howard Hughes Investigator. Dr. Witte is well known for his work in leukemia … Continue reading New developments in prostate cancer from UCLA
Using baking ingredient to create “nano” bombs and destroy cancer stem cells
"I am not a cook". Richard Nixon and the baking ingredient that could help win the "war on cancer" In 1971 President Richard Nixon declared a “war on cancer” and signed the National Cancer Act into law. Forty years later we’re still waging that war, and cancer is still one of the leading causes of … Continue reading Using baking ingredient to create “nano” bombs and destroy cancer stem cells
The Stem Cellar 